Skin Imaging Can Show Structure. Delivery Needs Its Own Test.
LC-OCT can reveal living skin in fine detail. It does not, on its own, show where an active ingredient travels or whether a formulation works.
A clearer view of living skin
In its June 2026 materials, L’Oréal presented DAMAE’s line-field confocal optical coherence tomography (LC-OCT) as a way to image living skin in real time and examine tissue organization. That is a description of an imaging capability, not a result for a named skincare formula. [1]
An earlier peer-reviewed study explains what the method can resolve. Ogien and colleagues demonstrated vertical and horizontal views of living human skin at approximately one-micrometre spatial resolution. Their images identified epidermal layers, keratinocyte nuclei, the dermal-epidermal junction and structures in the dermis. The study tested an imaging method in healthy skin; it did not test an ingredient, a formulation or a delivery system. [2]
An image has a defined question
A vertical view helps locate a structure by depth. A horizontal view examines a selected layer. Together, they can make a vague phrase such as “deeper in skin” more precise: which layer, which structure, and under what observation conditions? Those are useful questions when a team defines a target tissue.
But seeing skin architecture is different from measuring an active ingredient. A structural LC-OCT image alone cannot establish that a molecule crossed the barrier, remained at the intended site, was released from its formulation or produced a clinical benefit. Such claims need experiments designed around the molecule and the intended endpoint. This is an inference about what the cited imaging study measured; it is not a reported negative result for any product. [2]
Match the measurement to the delivery goal
For a formulation program, the starting question can be specific: where should the active go, and what result would show it arrived? Imaging may help define tissue context. Measuring distribution, retention, release or tissue response then requires suitable additional methods and a finished formulation tested under relevant conditions.
More detailed skin data does not automatically yield a better product. It can make the next experiment better framed. The value lies in keeping the observation, delivery claim and product outcome separate until each has its own evidence.